You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 6, June 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 90TH ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, KANSAS CITY, MO, NOV 15-17, 1982-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Improvement in Heart Disease Risk Factors After Gastric Bypass

John J. Gleysteen, MD; Joseph J. Barboriak, ScD

Arch Surg. 1983;118(6):681-684.


Abstract

• Fasting blood levels of three lipid classes (high-density lipoprotein—cholesterol [HDL-C], total cholesterol, and triglycerides) were measured in morbidly obese patients before, and six and 12 months after, Roux-en-Y gastric bypass. Weight above ideal in 31 women averaged 72 kg, and in 12 men, 78 kg. Excess weight lost after six months was 49.7%. Total cholesterol levels and abnormally high triglyceride levels (183±106 mg/dL [SD]) decreased and became normal after six months. Low-normal HDL-C levels in 31 women (45±13 mg/dL) improved by six months to 54±19 mg/dL; similarly, HDL-C levels in 12 men (38±9 mg/dL) increased to 57±17 mg/dL. One of eight diabetic patients remained hyperglycemic; ten of 15 patients who were hypertensive, requiring medication preoperatively, became normotensive by six months. Lipid levels measured again at one year showed little change. Risk factors of coronary heart disease were improved by gastric bypass in these morbidly obese patients, and the changes were clearly established by six months after operation.

(Arch Surg 1983;118:681-684)



Author Affiliations

From the Departments of Surgery (Dr Gleysteen) and Pharmacology (Dr Barboriak), Medical College of Wisconsin, Milwaukee, and Veteran's Administration Medical Center, Wood, Wis.


Footnotes

Accepted for publication Jan 17, 1983.

Read before the 90th annual meeting of the Western Surgical Association, Kansas City, Mo, Nov 17, 1982.

Reprint requests to Department of Surgery, Medical College of Wisconsin, 8700 W Wisconsin Ave, Milwaukee, WI 53226 (Dr Gleysteen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Return to Work After Gastric Bypass in Medicaid-Funded Morbidly Obese Patients
Wagner et al.
Arch Surg 2007;142:935-940.
ABSTRACT | FULL TEXT  

Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome: A long-term follow-up study
Scopinaro et al.
Diabetes Care 2005;28:2406-2411.
ABSTRACT | FULL TEXT  

Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
Faraj et al.
J. Clin. Endocrinol. Metab. 2003;88:1594-1602.
ABSTRACT | FULL TEXT  

Quality of Life: Cost and Future of Bariatric Surgery
Livingston and Fink
Arch Surg 2003;138:383-388.
FULL TEXT  

The Effect of Gastric Bypass Surgery on Hypertension in Morbidly Obese Patients
Carson et al.
Arch Intern Med 1994;154:193-200.
ABSTRACT  

Questions and Answers
JAMA 1989;261:1491-1494.
 

Reversal of Benign Intracranial Hypertension by Surgically Induced Weight Loss
Amaral et al.
Arch Surg 1987;122:946-949.
ABSTRACT  

Morbid Obesity and Related Health Risks
KRAL
ANN INTERN MED 1985;103:1043-1047.
ABSTRACT  

Gastric Restrictive Surgery for Morbid Obesity
Kral
JAMA 1985;254:2410-2411.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.